Login
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
.......... Issued in the interest of Investors"
OTP Verification
Regenerate OTP
Alert Message
Please contact to emkayassist@emkayglobal.com
Select Mobile Number and Email for OTP
Please select Mobile No and Email Id for OTP
Generate password
Customer Guest
Login | Register
Forgot Customer Code
Login | Register|Forgot password?
Would you like to create a personalised login id for logging in to Emkay Website ?
Change Personalised Login ID
Intimation under regulation 30 - Appointment of Director and Resignation of Managing Directormore...
Intimation under Regulation 30-Appointment of Director and Resignation of Managing Directormore...
As of June 2026 65.65% is owned by Indian Promoters and 34.36% by Public. Top five Promoters holding highest number of shares of Kabra Commercial com...more...
Pursuant to the Regulation 13(3) of SEBI (LODR) Regulation 2015 please find enclosed herewith Statement of Investors Complaints for the quar...more...
Regulation 74(5) of SEBI(Depositories and Participants) Regulations 2018 please find enclosed herewith certificate received from RTA for the quarter ...more...
The company reported standalone net loss during the quarter stood at Rs 1.04 crore as compared to net loss of Rs 1.73 crore in the previous ...more...
Approval of financial result for the quarter and year ended 31032026more...
Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that the ...more...
Kabra Commercial Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and ...more...
Statement of Investors Complaints enclosedmore...
As of March 2026 65.65% is owned by Indian Promoters and 34.36% by Public. Top five Promoters holding highest number of shares of Kabra Commercial co...more...
Enclosed Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the Quarter ended 31.03.2026more...
Enclosed herewith the disclosure under Regulation 31(4) of Securities and Exchange Board of Indiamore...
Enclosed herewith intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015more...
Please find enclosed herewith intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015more...
The company reported standalone net profit of Rs 0.73 crore for the quarter ended December 31 2025 as compared to Rs 0.38 crore in the same ...more...
Approval of unaudited financial result for the quarter and nine months ended 31122025more...
Approval of Unaudited Financial Results of the Company for the quarter and nine months ended 31st December 2025more...
Kabra Commercial Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and ...more...
BOARD MEETINGS Company Name : Alembic Pharma. Date : 04-08-2026
Latest Videos